Metoprolol succinate
Betaloc ZOK 100 and Betaloc ZOKare different trade names for the same medicine.
Betaloc ZOK 100 contains the active substance metoprolol, which belongs to a group of medicines called beta-blockers.
Metoprolol reduces the effect of stress hormones on the heart during physical and mental exertion.
This leads to a slowing of the heart rate (reduction of heart rate).
Betaloc ZOK 100 is used in the treatment of:
Betaloc ZOK 100 is used to treat high blood pressure (hypertension) in children and adolescents from 6 to 18 years of age.
Before starting treatment with Betaloc ZOK 100, the patient should discuss it with their doctor.
The patient should inform their doctor if they have:
The patient should consult their doctor, even if the above warnings refer to past situations.
Before planned anesthesia, the patient should inform their dentist or anesthesiologist about taking Betaloc ZOK 100.
The patient should not suddenly stop taking Betaloc ZOK 100. If it is necessary to stop treatment, the medicine should be discontinued gradually, if possible, over a period of at least two weeks, in decreasing doses, to half a 25 mg tablet once a day, for at least four days before completely stopping the medicine.
The patient should tell their doctor about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take. This includes eye drops, injectable medicines, over-the-counter medicines, including herbal medicines and dietary supplements. Some medicines may affect the action of other medicines. The patient should consult their doctor if they are taking any of the following medicines:
Consuming alcohol while taking metoprolol may enhance the effect of the medicine.
If the patient is pregnant, thinks they may be pregnant, or plans to have a child, they should consult their doctor before taking this medicine.
Pregnancy
Betaloc ZOK 100 should not be taken by pregnant women, unless the benefits of its use outweigh the risks to the fetus. In general, beta-blockers, including metoprolol, may cause fetal damage and premature birth.
If a woman taking Betaloc ZOK 100 becomes pregnant, she should inform her doctor as soon as possible.
Breastfeeding
Betaloc ZOK 100 should not be taken during breastfeeding, unless the benefits of its use outweigh the risks to the breastfed child.
The patient should check their individual reaction to Betaloc ZOK 100, as it may cause dizziness or fatigue that affects physical and mental performance.
This medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is considered "sodium-free".
This medicine should always be taken as directed by the doctor. If the patient has any doubts, they should consult their doctor or pharmacist.
Tablets of Betaloc ZOK 100 (or their halves) should not be chewed or crushed. The tablets (or their halves) should be swallowed with a liquid.
It is usually recommended to take Betaloc ZOK 100 once a day, with or without food.
The doctor will inform the patient how and when to take the tablets.
Available are: Betaloc ZOK 25 (23.75 mg), Betaloc ZOK 50 (47.5 mg), and Betaloc ZOK 100 (95 mg).
Hypertension
Adults
The recommended dose of Betaloc ZOK 100 for patients with mild to moderate hypertension is 50 mg once a day. If the response to the 50 mg dose is insufficient, the doctor may increase it to 100-200 mg once a day and (or) add another blood pressure-lowering medicine.
Children and adolescents
In children and adolescents over 6 years of age, the dose depends on the child's body weight. The doctor will determine the appropriate dose.
The usual initial dose is 1 mg/kg body weight, not more than 50 mg, given once a day in the form of a tablet with a strength close to the estimated dose.
The doctor may increase the dose to 2 mg/kg body weight, depending on the achieved blood pressure values.
Betaloc ZOK 100 should not be taken by children under 6 years of age.
Angina pectoris
The recommended dose of Betaloc ZOK 100 is 100-200 mg once a day. If necessary, the doctor may prescribe Betaloc ZOK 100 in combination with other medicines used to treat angina pectoris.
Symptomatic, chronic heart failure
The dose will be determined by the doctor. The recommended initial dose is one 25 mg tablet once a day for the first two weeks of treatment. Patients with more severe heart failure may be advised by the doctor to take half a 25 mg tablet once a day for the first week of treatment.
Then, the doctor will double the dose every two weeks, up to a maximum dose of 200 mg once a day or the maximum dose tolerated by the patient.
Arrhythmias
The recommended dose of Betaloc ZOK 100 is 100-200 mg once a day.
Functional heart disorders with palpitations
The recommended dose is 100 mg once a day. If necessary, the doctor may increase the dose to 200 mg once a day.
Prevention of another heart attack or sudden death after the acute phase of a heart attack
The recommended dose is 200 mg once a day.
Migraine prophylaxis
The recommended dose is from 100 mg to 200 mg once a day.
If the patient feels that the effect of Betaloc ZOK 100 is too strong or too weak, they should consult their doctor or pharmacist.
In case of taking a higher dose of Betaloc ZOK 100 than recommended, the patient should immediately consult their doctor or go to the emergency department of the nearest hospital.
In case of significant overdose, the following symptoms may occur: slow or irregular heart rate, shortness of breath, swelling of the ankles, feeling of strong heartbeat, dizziness, fainting, pain or pressure in the chest, cold skin, weak pulse, confusion, anxiety, cardiac arrest, partial or complete loss of consciousness/coma, nausea, vomiting, and cyanosis.
The patient should not take a double dose to make up for a missed dose.
If the patient misses a dose of Betaloc ZOK 100 and it is less than 12 hours since the planned time of taking the dose, they should take the missed dose immediately. If the patient remembers about the missed dose after 12 or more hours, they should skip the missed dose. The next dose should be taken at the usual time.
Like all medicines, Betaloc ZOK 100 can cause side effects, although not everybody gets them.
The following side effects may occur when taking this medicine.
˗
depression,
˗
insomnia,
˗
nightmares,
˗
concentration disorders,
˗
drowsiness,
˗
feeling of burning, tingling, or numbness (paresthesia),
˗
worsening of existing heart failure,
˗
conduction disorders in the heart, detected in the ECG (first-degree atrioventricular block),
˗
sudden drop in blood pressure during a heart attack (cardiogenic shock),
˗
bronchospasm,
˗
vomiting,
˗
skin rash,
˗
increased sweating,
˗
muscle cramps,
˗
joint pain,
˗
edema,
˗
weight gain.
When taking this medicine, the following conditions may worsen:
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. By reporting side effects, more information can be gathered on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Store in a temperature below 30 °C, in the original packaging.
Do not use this medicine after the expiry date stated on the packaging.
The expiry date refers to the last day of the month.
Do not take this medicine if the packaging is damaged.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
White or almost white, round tablets with a diameter of 10 mm, with a notch on one side, marked with "A/mS" on the other side. The notch line is designed to facilitate breaking the tablet, solely to make it easier to swallow, and not to divide the tablet into equal doses.
A HDPE bottle containing 30 prolonged-release tablets, in a cardboard box.
Recordati Industria Chimica e Farmaceutica S.p.A., Via Matteo Civitali 1, 20148 Milan, Italy
AstraZeneca AB, Gärtunavägen, SE-151 85 Södertälje, Sweden
Casen Recordati, S.L., Autovía de Logroño, Km 13,300, 50180 Utebo, Saragossa, Spain
Parallel importer:
PharmaVitae Sp. z o.o. Sp. k., ul. E. Orzeszkowej 3/35, 59-820 Leśna
Repackaged by:
Pharma Innovations Sp. z o.o., ul. Jagiellońska 76, 03-301 Warsaw
Synoptis Industrial Sp. z o.o., ul. Szosa Bydgoska 58, 87-100 Toruń
Prespack Jacek Karoński, ul. Św. Wawrzyńca 34, 60-541 Poznań
CEFEA Sp. z o.o. sp. komandytowa, ul. Działkowa 56, 02-234 Warsaw
Authorization number in Romania, the country of export: 7136/2014/01
Parallel import authorization number: 136/17
Date of leaflet approval: 20.04.2022
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.